OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.560
+0.050 (3.31%)
Jul 21, 2026, 11:37 AM EDT - Market open
OS Therapies Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, OS Therapies stock has a consensus rating of "Strong Buy" and an average price target of $8.92. The average 1-year stock price forecast is 471.79% higher than the current stock price, while the lowest is $6.00 (+284.62%) and the highest is $13 (+733.33%).
Price Target: $8.92 (+471.79%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for OS Therapies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Initiates $7 | Buy | Initiates | $7 | +348.72% | Jul 10, 2026 |
| Lake Street | Lake Street | Buy Maintains $13 | Buy | Maintains | $13 | +733.33% | Jul 7, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $6 | Buy | Maintains | $6 | +284.62% | May 20, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
30.19M
EPS This Year
-0.78
from -1.03
EPS Next Year
0.36
from -0.78
EPS and Forward PE are based on non-GAAP adjusted numbers.